Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Aptamer Group Ltd, the developer of custom affinity tools to enable the life science industry through its proprietary Optimer platform, and Bio-Works Technologies AB, the developer and manufacturer of leading-edge agarose-based purification ...
read more
Aptamer Group, the developer of diagnostic and therapeutic Optimer™ reagents, announced that it has signed an agreement with the multinational pharmaceutical and biopharmaceutical company Takeda Pharmaceutical Company Limited (“Takeda”).
read more
Wednesday, September 03, 2025
Aptamer Group ,a developer of synthetic binders for the life science industry, announced the launch of its biomarker discovery service, offering researchers in pharmaceutical, biotechnology, and diagnostic development an innovative approach to ...
read more
Thursday, August 28, 2025
Aptamer Group announced the launch of its biomarker discovery service, offering researchers in pharmaceutical, biotechnology, and diagnostic development an innovative approach to identify and validate new disease markers.
read more
Thursday, December 14, 2023
Aptamer Group plc, renowned for pioneering Optimer® binders that drive innovation in the life sciences sector, has formalized a substantial agreement with a biotechnology company specializing in genetic medicines.
read more
Aptamer Group announced a commercial partnership with Mologic, a developer and manufacturer of lateral flow and rapid diagnostic tests.
read more
Aptamer Group, developer of Optimer™ reagents and therapeutics, has announced the extension of their current agreement with AstraZeneca, a global biopharmaceutical company.
read more
Friday, November 01, 2019
AptarGroup has acquired drug delivery training devices and patient onboarding company Noble International.
read more
Tuesday, October 19, 2021
Aptar CSP Technologies, part of AptarGroup, Inc., and a leader in active material science solutions that ensure product protection, extend shelf life and improve user experience, was awarded a $19 million contract from the U.S. government. This award...
read more
Thursday, September 08, 2022
Aptar Pharma has acquired Metaphase Design Group, a leader in applying the science of human factors engineering and ergonomics to product design.
read more
Wednesday, November 04, 2020
AptarGroup has acquired all operating assets and the proprietary portfolio of Cohero Health.
read more
Wednesday, October 27, 2021
Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, and i2c Pharmaceutical Services, a leading service provider for the development of pharmaceutical formulations, today announced an exclusive ...
read more
Aptar Pharma, part of AptarGroup, Inc., announced the next phase of its global capacity expansion plan in North America, at its Aptar Congers, New York site.
read more
Tuesday, October 26, 2021
Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, announced an exclusive partnership with Stallergenes Greer, a global healthcare company specializing in allergen immunotherapy (AIT), for the ...
read more
Aptar Pharma acquired worldwide rights to Pharmaxis’ proprietary Orbital™ inhaler, a unique device that can deliver high payload dry powder to the lungs.
read more